# Safety Study of VM202 to Treat Amyotrophic Lateral Sclerosis

> **NCT02039401** · PHASE1,PHASE2 · COMPLETED · sponsor: **Helixmith Co., Ltd.** · enrollment: 18 (actual)

## Conditions studied

- Amyotrophic Lateral Sclerosis

## Interventions

- **BIOLOGICAL:** VM202

## Key facts

- **NCT ID:** NCT02039401
- **Lead sponsor:** Helixmith Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03-11
- **Primary completion:** 2015-08-03
- **Final completion:** 2024-03-06
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2025-10-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02039401

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02039401, "Safety Study of VM202 to Treat Amyotrophic Lateral Sclerosis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02039401. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*